cyclo[DL-N(Me)Ala-DL-OVal-DL-N(Me)Val-DL-OVal-DL-N(Me)Val-DL-OVal]

Details

Top
Internal ID aa38fc37-5e53-4f60-bd20-a753b7ca87a9
Taxonomy Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides
IUPAC Name 3,4,10,16-tetramethyl-6,9,12,15,18-penta(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C31H53N3O9/c1-15(2)21-30(39)42-23(17(5)6)26(35)32(12)20(11)29(38)41-24(18(7)8)27(36)33(13)22(16(3)4)31(40)43-25(19(9)10)28(37)34(21)14/h15-25H,1-14H3
InChI Key IEUFDXNGDNWAKU-UHFFFAOYSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C31H53N3O9
Molecular Weight 611.80 g/mol
Exact Mass 611.37818028 g/mol
Topological Polar Surface Area (TPSA) 140.00 Ų
XlogP 5.60
Atomic LogP (AlogP) 2.52
H-Bond Acceptor 9
H-Bond Donor 0
Rotatable Bonds 5

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of cyclo[DL-N(Me)Ala-DL-OVal-DL-N(Me)Val-DL-OVal-DL-N(Me)Val-DL-OVal]

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.5000 50.00%
Caco-2 - 0.6821 68.21%
Blood Brain Barrier + 0.6500 65.00%
Human oral bioavailability + 0.5857 58.57%
Subcellular localzation Mitochondria 0.5190 51.90%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9301 93.01%
OATP1B3 inhibitior + 0.9402 94.02%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.9013 90.13%
P-glycoprotein inhibitior + 0.7034 70.34%
P-glycoprotein substrate - 0.7945 79.45%
CYP3A4 substrate - 0.5775 57.75%
CYP2C9 substrate + 0.5963 59.63%
CYP2D6 substrate - 0.8895 88.95%
CYP3A4 inhibition - 0.9484 94.84%
CYP2C9 inhibition - 0.9077 90.77%
CYP2C19 inhibition - 0.9112 91.12%
CYP2D6 inhibition - 0.9540 95.40%
CYP1A2 inhibition - 0.9384 93.84%
CYP2C8 inhibition - 0.9953 99.53%
CYP inhibitory promiscuity - 0.9883 98.83%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8007 80.07%
Carcinogenicity (trinary) Non-required 0.6653 66.53%
Eye corrosion - 0.9637 96.37%
Eye irritation - 0.8576 85.76%
Skin irritation - 0.7918 79.18%
Skin corrosion - 0.9433 94.33%
Ames mutagenesis - 0.5600 56.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5528 55.28%
Micronuclear + 0.7300 73.00%
Hepatotoxicity + 0.6551 65.51%
skin sensitisation - 0.9188 91.88%
Respiratory toxicity - 0.5222 52.22%
Reproductive toxicity + 0.6222 62.22%
Mitochondrial toxicity + 0.5337 53.37%
Nephrotoxicity + 0.4899 48.99%
Acute Oral Toxicity (c) III 0.5560 55.60%
Estrogen receptor binding + 0.7257 72.57%
Androgen receptor binding + 0.5282 52.82%
Thyroid receptor binding + 0.5931 59.31%
Glucocorticoid receptor binding - 0.5316 53.16%
Aromatase binding + 0.5300 53.00%
PPAR gamma + 0.5597 55.97%
Honey bee toxicity - 0.8846 88.46%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity - 0.5200 52.00%
Fish aquatic toxicity - 0.8273 82.73%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 95.31% 97.25%
CHEMBL2581 P07339 Cathepsin D 91.07% 98.95%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 88.65% 96.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 86.87% 95.56%
CHEMBL1949 P62937 Cyclophilin A 84.96% 98.57%
CHEMBL1907 P15144 Aminopeptidase N 82.66% 93.31%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 82.44% 90.71%
CHEMBL4072 P07858 Cathepsin B 80.45% 93.67%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Pinus sylvestris

Cross-Links

Top
PubChem 73114137
LOTUS LTS0103862
wikiData Q104168720